600
Participants
Start Date
May 22, 2017
Primary Completion Date
May 10, 2027
Study Completion Date
May 10, 2027
Ibrutinib
Subjects will continue with the current ibrutinib dosing regimen established in the parent ibrutinib study.
National Taiwan University Hospital, Taipei
Central Hospital of Southern Pest - National Institute of Hematology and Infectious Diseases, Dept of Hematology and Stem Cell, Budapest
Middlemore Hospital, Papatoetoe
Concord Repatriation General Hospital - Haematology Clinical Trials, Sydney
St. George Hospital, Kogarah
Peter MacCallum Cancer Centre, Melbourne
St Vincent Hospital, Fitzroy
Eastern Health, Box Hill
Monash Health-Monash Medical Centre, Clayton
Ballarat Health Services, Ballarat
Princess Alexandra Hospital, Woolloongabba
Flinders Medical Centre, Bedford Park
Weill Cornell Medical College-New York Presbyterian Hospital, New York
Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino
Northwell Health, New Hyde Park
Charles University Hospital, Prague, Prague
University of Rochester, Rochester
CNE CCOHTPC of Cherkasy Regional Council, Cherkasy
University of Pennsylvania Abramson Cancer Center, Philadelphia
Pamukkale University Medical Faculty, Denizli
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan
Ospedale San Raffaele IRCCS, Milan
ASST Grande Ospedale Metropolitano Niguarda, Milan
Centre Hospitalier Saint Brieuc, Saint-Brieuc
Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia
Hospital Universitario 12 de Octubre, Madrid
Levine Cancer Institute, Charlotte
Hospital Universitario Puerta de Hierro, Majadahonda
Emory University, Atlanta
University Hospital Pilsen, Pilsen
Azienda Sanitaria Universitaria Integrata Udine, Udine
VKV American Hospital, Istanbul
Azienda Ospedaliera di Padova, Padua
Dokuz Eylul University, Izmir
University Hospital of Salamanca, Salamanca
Vanderbilt Ingram Cancer Center, Nashville
Norton Medical Plaza II, 3991 Dutchmans Lane, Louisville
China Medical University Hospital, Taichung
Kyungpook National University Hospital (KNUH), Daegu
The Ohio State University, Columbus
Mid Ohio Oncology/Hematology Inc., DBA The Mark H. Zangmeister Center, Columbus
CHU Hotel Dieu, Nantes
Cleveland Clinic, Cleveland
University of Cincinnati Medical Center, Cincinnati
Henry Ford Health System, Detroit
CNCE City Clinical Hospital 4 of Dnipro City Council, Dnipro
University Hospital Hradec Kralove, Hradec Králové
Södra Älvsborg Hospital Borås, Borås
Northwestern University, Chicago
University of Chicago, Chicago
Hematology and Oncology Masaryk University Hospital Brno, Brno
Centre Henri Becquerel, Rouen
M.D. Anderson Cancer Centre, Houston
US Oncology Research, LLC, The Woodlands
SI Institute of Blood Pathology and Transfusion Medicine of AMSU, Lviv
San Juan Oncology Associates, Farmington
University of California Los Angeles (UCLA), Los Angeles
City Of Hope National Medical Center, Duarte
Providence Health System - Southern California d/b/a Roy and Patricia Disney Family Cancer Center, The Roy & Patricia Disney Family Cancer Center, Burbank
Stanford University, Stanford
Sunderby hospital, Luleå
Swedish Cancer Institute, Seattle
Wenatchee Valley Hospital and Clinics, Wenatchee
Yakima Valley Memorial Hospital, Yakima
Yaroslavl Regional Clinical Hospital, Yaroslavl
Russian Scientific and Research Institute of Hematology and Transfusiology of Federal Medical Biological Agency, Saint Petersburg
Almazov National Medical Research Centre, Saint Petersburg
"SBI of Ryazan region Regional Clinical Hospital", Ryazan
Nizhniy Novgorod Regional Clinical Hospital n.a. N.A. Semashko, Nizhny Novgorod
UCSD Moores Cancer Center, La Jolla
Dana-Farber Cancer Institute, Boston
TRIO - Comprehensive Cancer Centers of Nevada, Las Vegas
John Theurer Cancer Center, Hackensack UMC, Hackensack
Memorial Sloan Kettering Cancer Center, New York
Southeastern Medical Oncology Center, Goldsboro
University of Texas MD Anderson Cancer Center, Houston
University of Vermont Medical Center, Burlington
Northwest Cancer Specialists, Compass Oncology, Vancouver
QEII Health Science Centre, Halifax
Princess Margaret Cancer Centre, Toronto
McGill University Health Center, Montreal
Fakultni nemocnice Kralovske Vinohrady, Prague
North Shore Hospital, Auckland
Szpital Specjalistyczny w Brzozowie, Oddział Hematologii Onkologicznej z Klinicznym Oddziałem Przeszczepiania Szpiku, Brzozów
Klinika Hematologii i Transplantologii, Gdansk
SPZOZ ZSM w Chorzowie, Chorzów
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika, Lodz
ICO - Hospital Germans Trias I Pujol, Badalona
Hospital de Sanata Creus i Sant Pau, Barcelona
ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona
Hospital Vall d'Hebron, Barcelona
Karolinska Universitetssjukhuset, Solna, Solna
Ankara Universitesi Tip Fakultesi Hastanesi, Ankara
Gazi University, Ankara
University Hospital of Wales, Cardiff
Leeds Teaching Hospitals NHS, Leeds
University College Hospitals NHS Foundation Trust, London
The Christie NHS Foundation Trust, Manchester
Janssen Biotech, Inc., including Johnson & Johnson
UNKNOWN
Pharmacyclics Switzerland GmbH
INDUSTRY